CJC-1295 w/DAC

CJC-1295 (with DAC) – Research Compound (5 mg)

GHRH Analog Peptide for Laboratory Research

CJC-1295 with DAC is a synthetic growth hormone–releasing hormone (GHRH) analog supplied as a lyophilized peptide for controlled scientific investigation involving endocrine signaling pathways and peptide-receptor interaction studies. The addition of the DAC (Drug Affinity Complex) modification is designed to extend peptide stability in laboratory models, making this compound suitable for prolonged signaling and receptor pathway analysis under controlled experimental conditions.

Within research environments, CJC-1295 with DAC is commonly utilized in studies involving GHRH receptor interaction, intracellular signaling behavior, and peptide-mediated molecular communication systems. Researchers may investigate this peptide in controlled laboratory settings focused on endocrine-related pathway analysis and sustained peptide signaling mechanisms.

Due to its stabilized peptide structure and extended experimental stability profile, CJC-1295 with DAC is frequently referenced in scientific research involving growth hormone–related signaling pathways and controlled in vitro peptide investigation.

This product is manufactured and distributed exclusively for scientific and educational laboratory research applications.

Product Specifications

• Quantity: 5mg per vial
• Form: Lyophilized powder
• Appearance: White to off-white solid
• Molecular Weight: Approximately 3647.85 Da
• Storage (Unreconstituted): Store refrigerated at 2°C–8°C in a dry, dark location
• Storage (Reconstituted): Refrigerate at 2°C–8°C

Laboratory Research Information

CJC-1295 with DAC is commonly studied in laboratory environments involving endocrine signaling pathways, receptor interaction analysis, and peptide-mediated molecular communication systems. Researchers may utilize this compound in controlled in vitro settings focused on sustained peptide signaling behavior, receptor-binding investigation, and intracellular pathway analysis.

Laboratory applications may include:

• GHRH receptor interaction studies
• Endocrine signaling pathway analysis
• Peptide stability and signaling research
• Intracellular communication pathway investigation
• Growth hormone–related molecular studies
• Controlled peptide-receptor experimental models

This peptide compound is intended exclusively for scientific and educational laboratory investigation.

Storage & Handling Guidelines

For optimal stability, unreconstituted CJC-1295 with DAC should be stored refrigerated at 2°C–8°C in a dry environment protected from moisture and direct light exposure. Once reconstituted, peptide solutions should remain refrigerated and handled using sterile laboratory procedures.

Researchers should minimize repeated freeze-thaw cycles whenever possible to help preserve peptide stability and maintain experimental consistency.

Research Use Only

This product is intended strictly for laboratory and scientific research purposes only.

It is not intended for:

• Human consumption
• Animal consumption
• Clinical applications
• Diagnostic procedures
• Therapeutic use
• Dietary supplementation
• Cosmetic use
• Veterinary applications

This product has not been evaluated or approved by the FDA or any other regulatory authority.

Disclaimer

All information provided is intended solely for scientific and educational research reference purposes. No claims are made regarding safety, efficacy, or suitability for any specific research application or experimental outcome.

The purchaser and handling laboratory assume full responsibility for proper handling, storage, use, and disposal in accordance with all applicable local, state, and federal regulations.